| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/27/2002 | US20020082408 GSK3 polypeptides |
| 06/27/2002 | US20020082407 Novel human GABA receptors and polynucleotides encoding the same |
| 06/27/2002 | US20020082406 Novel human kinase interacting protein and polynucleotides encoding the same |
| 06/27/2002 | US20020082405 Novel human transporter proteins and polynucleotides encoding the same |
| 06/27/2002 | US20020082402 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/27/2002 | US20020082397 Novel receptor-type phosphotyrosine phosphatase-kappa |
| 06/27/2002 | US20020082396 Reshaped human antibody to human interleukin-8 |
| 06/27/2002 | US20020082395 Immunoglobulin for use in diagnosis, treatment and prevention of bacterial infections |
| 06/27/2002 | US20020082392 Antibodies to cell-cycle regulatory proteins, and uses related thereto |
| 06/27/2002 | US20020082388 Polypeptide for use in the treatment, diagnosis and prevention of cancer, nervous system and developmental disorders |
| 06/27/2002 | US20020082387 Novel proline-rich membrane protein |
| 06/27/2002 | US20020082385 Protein for use in dietetics and the treatment of diabebtes |
| 06/27/2002 | US20020082237 Complexing a cationic polymer and/or cationic lipid with a polynucleotide in the presence of detergent, removing the detergent whereby a stable polynucleotide dellivery vehicle is produced |
| 06/27/2002 | US20020082236 A double stranded nucleic acid molecules with a first strand comprises an RNA sequence which codes for a protein of interest linked downstream of a flanking sequence and a translation initiation site inserted upstream of the RNA |
| 06/27/2002 | US20020082234 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 06/27/2002 | US20020082232 Transgenic mice containing NPY6-R neuropeptide receptor gene disruptions |
| 06/27/2002 | US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds |
| 06/27/2002 | US20020082230 Introducing an antisense oligomer into a cell, allowing the oligomer to hybridize to the mRNA of IL-15, thereby inhibiting the production of IL-15 |
| 06/27/2002 | US20020082228 Specific oligonucleotides (8-50 nucleobses) hybridize with nucleic acids encoding BH3 Interacting domain Death agonist |
| 06/27/2002 | US20020082227 An ester linkage moieties of the oligonucleotide is replaced with a thioate linkage, such as phosphrothioates, useful as therapies for treating abnormal/undesirable conditions which can arise as a result of complement activation |
| 06/27/2002 | US20020082226 Antisense antibacterial method and composition |
| 06/27/2002 | US20020082225 Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis c virus infection |
| 06/27/2002 | US20020082224 Non-immunogenic prodrugs and selectable markers for use in gene therapy |
| 06/27/2002 | US20020082217 Synthetic compounds, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds, and immune effector cells raised in response to presentation of these epitopes |
| 06/27/2002 | US20020082212 7716, a novel human ATPase and uses therefor |
| 06/27/2002 | US20020082211 Human presenilin variant |
| 06/27/2002 | US20020082207 Comprising pancreatic tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, T cells specific for cells expressing such polypeptides |
| 06/27/2002 | US20020082205 Human FGF-23 gene and gene expression products |
| 06/27/2002 | US20020082203 Novel sphingosine kinases |
| 06/27/2002 | US20020082202 Screening methods using ligands of the neutropeptide receptor HFGAN72 |
| 06/27/2002 | US20020082191 Amino acid sequences of the transport proteins encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; brain disorders |
| 06/27/2002 | US20020082190 Amino acid sequences of the transport proteins encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; brain disorders |
| 06/27/2002 | US20020081751 Spheres; for use in the color separation |
| 06/27/2002 | US20020081739 Genetically engineering cells; obtain cell, obtain nucleotide sequences, adhere sequences to sheets, propel sheet into cells, recover transformed cells |
| 06/27/2002 | US20020081737 Generating biocompatible bead; obtain bead, incubate with probes, immobilize probe to bead, recover bead |
| 06/27/2002 | US20020081736 Transferring nucleotide sequences into cells; generate mixture of dextrin, sucrose and nucleotide sequences, incubate with cell, recover transformed cells |
| 06/27/2002 | US20020081735 Of given nucleotide sequence, operably linked to a DNA sequence encoding a structural gene |
| 06/27/2002 | US20020081734 Modified muteins of erythropoietin derived from in vitro or in vivo expression system of microorganism |
| 06/27/2002 | US20020081733 Method to prepare drug-resistant, non-malignant hematopoietic cells |
| 06/27/2002 | US20020081730 HVD1 gene induced by salt stress |
| 06/27/2002 | US20020081724 Culture of stem cells; for use in human therapeutics |
| 06/27/2002 | US20020081723 Respiratory syncytial virus (RSV) fusion protein; treating or preventing RSV infection, as well as for diagnosis of RSV in analytes |
| 06/27/2002 | US20020081722 Nucleotide sequences coding preferential polypeptide for use in treatment and prevention of bacterial infection |
| 06/27/2002 | US20020081721 Aav split-packaging genes and cell lines comprising such genes for use in the production of recombinant aav vectors |
| 06/27/2002 | US20020081720 Receptor activator of NF-kappaB |
| 06/27/2002 | US20020081719 Inflammation inducible hybrid promoters, vectors comprising them and uses thereof |
| 06/27/2002 | US20020081718 Polypeptide, and a dna sequence to which a protein containing the polypetide binds |
| 06/27/2002 | US20020081716 Semiconductor element and device for detecting organic molecules and method for measuring organic molecules using same |
| 06/27/2002 | US20020081715 Biomolecule microarray support, biomolecule microarray using the support, and method of fabricating the support |
| 06/27/2002 | US20020081711 Expression vector for use in the reatment of solid tumors |
| 06/27/2002 | US20020081710 Purification of preferential viral particles; obtain solution containing viral particles, mix with polyelectrolyte, centrifuge, recover pellet, separate viral particles from pellet |
| 06/27/2002 | US20020081709 Expression vector for use as tool in genetic engineering |
| 06/27/2002 | US20020081708 Novel chimeric promoters |
| 06/27/2002 | US20020081707 Methods for helper-dependent adenoviral vector production |
| 06/27/2002 | US20020081706 Negative strand rna viral vector having autonomous replication capability |
| 06/27/2002 | US20020081705 Human caspase-14 compositions |
| 06/27/2002 | US20020081703 Reducing allegenic response heterologous proteins; obtain nucleotide sequences of heterologous protein, insert subtilisin sequences, transform cell, expression vector, recover protein, monitor human to protein |
| 06/27/2002 | US20020081702 Enzymatic polypetide for use in treatment of textiles, papermaking and animal feeds |
| 06/27/2002 | US20020081700 Polynucleotide encoding protein for use as tool in evaluating cell and tissue development |
| 06/27/2002 | US20020081697 Thermostable enzymes having aminotransferase activity, nucleic acids encoding them and methods of making and using them |
| 06/27/2002 | US20020081696 32529, a novel human guanine nucleotide exchange factor family member and uses thereof |
| 06/27/2002 | US20020081695 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 06/27/2002 | US20020081694 Enzymatic polypeptide for use in the diagnosis and treatment of tumors |
| 06/27/2002 | US20020081693 Plant caffeoyl-coa o-methyltransferase |
| 06/27/2002 | US20020081690 Hybrid enzyme and use thereof |
| 06/27/2002 | US20020081688 Retinoid pathway assays, and compositions therefrom |
| 06/27/2002 | US20020081687 Sitosterolemia susceptibility gene (SSG): compositions and methods of use |
| 06/27/2002 | US20020081685 Disintegrin homologs, ZSNK10, ZSNK11, and ZSNK12 |
| 06/27/2002 | US20020081684 Method and nucleotide sequence for transforming microorganisms |
| 06/27/2002 | US20020081683 Polypeptide for use in the diagnosis and treatment of psoriasis, infection, asthma and immune and respiratory disorders |
| 06/27/2002 | US20020081682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of bacterial infections |
| 06/27/2002 | US20020081674 Nucleotide sequences coding enzymatic polypeptide for generation of lysine and valine for use in human medicine and animal nutrients |
| 06/27/2002 | US20020081668 Nucleotide sequences for use in genomic analysis and human therapeutics |
| 06/27/2002 | US20020081667 Expression vector for use as tool in genetic engineering and the amplification of nucleotide sequences |
| 06/27/2002 | US20020081666 Preferentially cleaving nucleotide sequences, obtain nucleotide sequences, incubate with enzymatic polypeptide, recover nucleotide sequences |
| 06/27/2002 | US20020081665 Composition for use as immunomodulatory and anticarcinogenic agents |
| 06/27/2002 | US20020081664 Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 06/27/2002 | US20020081659 Nucleic acids, proteins and antibodies |
| 06/27/2002 | US20020081658 Nucleotide sequences coding membrane protein; for use treatment of nervous system disorders, Tourette's syndrome, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, Jakob- Creutzfieldt disease and sleep disorders |
| 06/27/2002 | US20020081657 21784, a novel human calcium channel family member and uses thereof |
| 06/27/2002 | US20020081656 UDP-N-acetylglucosamine: Galactose-beta1,3-N-acetylgalactosamine-alpha-R / N-acetylglucosamine-beta1,3,-N-acetylgalactosamine-alpha-R (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2/4GnT |
| 06/27/2002 | US20020081653 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/27/2002 | US20020081649 Peptide for use in human therapeutics and diagnostics; for use as a antitumor agent |
| 06/27/2002 | US20020081648 Peptide for use in human thereapeutics and diagnostics |
| 06/27/2002 | US20020081644 Encoded by a polynucleotide; use as reporter molecule |
| 06/27/2002 | US20020081633 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 06/27/2002 | US20020081625 Polynucleotide coding preferential polypeptide for use in mammalian therapeutics and diagnostics |
| 06/27/2002 | US20020081624 Detection of patients at risk for developing integrin antagonist/ agonist mediated disease states |
| 06/27/2002 | US20020081623 Chemotactic cytokine |
| 06/27/2002 | US20020081619 Separation of preferential nucleotide sequences; obtain sample, incubate with solid support, elute, recover preferential nucleotide sequences |
| 06/27/2002 | US20020081618 Sampling and storage system for genetic mateiral from tissue |
| 06/27/2002 | US20020081614 Functional genomics using zinc finger proteins |
| 06/27/2002 | US20020081613 Detecting cancer in a tissue sample; obtain tissue sample, screen for preferential marker, presence of marker indicates cancer |
| 06/27/2002 | US20020081607 Four disulfide core domain-containing (FDCD) polynucleotides, polypeptides, and antibodies |
| 06/27/2002 | US20020081605 Method for detecting growth hormone variations in humans, the variations and their uses |
| 06/27/2002 | US20020081604 Polypeptide for use in the treatment of diagnosis, prevention, and treatment of infectious, developmental, neoplastic, and immunological defects |
| 06/27/2002 | US20020081603 Isolating preferential polynucleotide sequences from library; obtain cellular chromatin, incubate with probe, fragment nucleotide sequences, recover marked polynucleotides |
| 06/27/2002 | US20020081601 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 06/27/2002 | US20020081600 Novel human kinase proteins and polynucleotides encoding the same |
| 06/27/2002 | US20020081597 Compositions and methods for detecting and quantifying gene expression |